Case Study: a USA-based pharmaceutical consultant successfully submits YY201 IND with Freyr regulatory support

a USA-based pharmaceutical consultant successfully submits YY201 IND to the USFDA with FREYR

A USA-based pharmaceutical consultant faced challenges due to a limited understanding of the regulatory submission process for an IND application to the USFDA and lacked experience in preparing the required Module 1 content. They engaged FREYR for expert regulatory assistance to ensure a compliant and timely submission.

FREYR provided a tailored regulatory strategy and conducted a comprehensive review of the IND application to identify gaps. Their expert guidance on Module 1 content ensured compliance with FDA regulations. This support enabled the client to successfully submit the YY201 IND to the USFDA on time and provided them with a clear understanding of regulatory expectations.